MARKET DEFINITION

Systems for delivering medications into or throughout the body are known as drug delivery systems. The delivery mechanism, such as a tablet or an injection of a vaccination, is one of these technologies. Medication "packaging"—such as a micelle or a nanoparticle—that shields the drug from deterioration and enables it to reach wherever it is needed in the body is referred to as drug delivery systems. In the last several decades, medication delivery has evolved significantly, and much more advancements are projected in the upcoming years. Biomedical engineers have made significant contributions to knowledge of the physiological obstacles to effective drug administration and have also helped design a number of innovative drug delivery methods that have entered the clinical setting.

MARKET DYNAMICS

The need for drug delivery systems has increased as a result of the advent of a new class of therapies in the biopharmaceutical sector, which offers considerable potential for novel treatments for diabetes, cancer, and other diseases. Additionally, the market is growing as a result of leading market participants' growing investments in drug delivery R&D. However, needle stick injuries are one of the greatest threats to an individual's health and safety, as it results in the risk of contracting blood-borne diseases which is restraining the growth of the drug delivery market. Nevertheless, self-administration and home care are predicted to offer the market for drug delivery with significant potential. Since older people make up a sizeable portion of the clientele for home care, the geriatric population is mostly to credited for this increase.

REPORT SCOPE

The report titled “Global Drug Delivery Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global Drug Delivery market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global Drug Delivery market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global Drug Delivery Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global Drug Delivery Market is segmented based on route of administration, application, distribution channel and region. Based on route of administration, the market has been segmented into Oral, Ocular, Pulmonary, Nasal, Injectable, Topical and Others, whereas based on application, the market comprises Cardiovascular, Diabetes, Cancer, Infectious Diseases and Others. Based on distribution channel, the market has been segmented into Hospital Pharmacies, Retail Pharmacies and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the Drug Delivery market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global Drug Delivery market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global Drug Delivery market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the Drug Delivery industry in the past three years.

Key players in the Global Drug Delivery Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• Johnson & Johnson Services, Inc.
• Novartis International AG
• Hoffmann-La Roche AG
• Pfizer Inc.
• Bayer AG
• Antares Pharma, Inc.
• Becton
• Dickinson and Company
• GlaxoSmithKline plc
• 3M
• Merck & Co., Inc.
• Sanofi

COVID-19 IMPACT ANALYSIS ON GLOBAL DRUG DELIVERY MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global Drug Delivery market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the Drug Delivery market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the Drug Delivery market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity

Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective

Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Route of Administration Trends
3.2.2. Application Trends
3.2.3. Distribution Channel Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global Drug Delivery Market
3.6. COVID-19 Impact Assessment in Drug Delivery Market
3.6.1. Impact Assessment on Global Drug Delivery Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape

Chapter 4. Global Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
4.1. Global Drug Delivery Market Share, By Route of Administration, 2017 - 2028 (USD Million)
4.1.1. Oral
4.1.2. Ocular
4.1.3. Pulmonary
4.1.4. Nasal
4.1.5. Injectable
4.1.6. Topical
4.1.7. Others

Chapter 5. Global Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
5.1. Global Drug Delivery Market Share, By Application, 2017 - 2028 (USD Million)
5.1.1. Cardiovascular
5.1.2. Diabetes
5.1.3. Cancer
5.1.4. Infectious Diseases
5.1.5. Others

Chapter 6. Global Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
6.1. Global Drug Delivery Market Share, By Distribution Channel, 2017 - 2028 (USD Million)
6.1.1. Hospital Pharmacies
6.1.2. Retail Pharmacies
6.1.3. Others

Chapter 7. Global Drug Delivery Market Overview, By Geography, 2017 - 2028 (USD Million)
7.1. Global Drug Delivery Market Share, By Geography, 2017 - 2028 (USD Million)
7.1.1. Market Size and Projections, by Countries, 2017 - 2028 (USD Million)
7.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)

Chapter 8. North America Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
8.1. North America Drug Delivery Market Overview, 2017 - 2028 (USD Million)
8.1.1. Market size and projections, 2017 - 2028 (USD Million)
8.1.2. North America Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
8.1.3. North America Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
8.1.4. North America Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2. North America Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
8.2.1. U.S. Drug Delivery Market Overview, 2017 - 2028 (USD Million)
8.2.1.1. U.S. Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
8.2.1.2. U.S. Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.1.3. U.S. Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2.2. Canada Drug Delivery Market Overview, 2017 - 2028 (USD Million)
8.2.2.1. Canada Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
8.2.2.2. Canada Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.2.3. Canada Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
8.2.3. Mexico Drug Delivery Market Overview, 2017 - 2028 (USD Million)
8.2.3.1. Mexico Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
8.2.3.2. Mexico Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
8.2.3.3. Mexico Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 9. Europe Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. Europe Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market size and projections, 2017 - 2028 (USD Million)
9.1.2. Europe Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.1.3. Europe Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.1.4. Europe Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2. Europe Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. Germany Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. Germany Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.1.2. Germany Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.1.3. Germany Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.2. France Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. France Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.2.2. France Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.2.3. France Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.3. UK Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. UK Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.3.2. UK Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.3.3. UK Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.4. Italy Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.4.1. Italy Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.4.2. Italy Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.4.3. Italy Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.5. Spain Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.5.1. Spain Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.5.2. Spain Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.5.3. Spain Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.6. NORDIC Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.6.1. NORDIC Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.6.2. NORDIC Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.6.3. NORDIC Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.7. Russia and CIS Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.7.1. Russia and CIS Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.7.2. Russia and CIS Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.7.3. Russia and CIS Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
9.2.8. Rest of Europe Drug Delivery Market Overview, 2017 - 2028 (USD Million)
9.2.8.1. Rest of Europe Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
9.2.8.2. Rest of Europe Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
9.2.8.3. Rest of Europe Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 10. Asia Pacific Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Asia Pacific Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market size and projections, 2017 - 2028 (USD Million)
10.1.2. Asia Pacific Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.1.3. Asia Pacific Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.1.4. Asia Pacific Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2. Asia Pacific Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. India Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. India Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.1.2. India Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.1.3. India Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.2. China Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. China Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.2.2. China Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.2.3. China Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.3. Japan Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. Japan Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.3.2. Japan Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.3.3. Japan Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.4. ASEAN Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. ASEAN Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.4.2. ASEAN Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.4.3. ASEAN Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.5. South Korea Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. South Korea Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.5.2. South Korea Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.5.3. South Korea Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.6. Australia Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. Australia Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.6.2. Australia Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.6.3. Australia Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
10.2.7. Rest of Asia Pacific Drug Delivery Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Rest of Asia Pacific Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
10.2.7.2. Rest of Asia Pacific Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
10.2.7.3. Rest of Asia Pacific Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 11. South America Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. South America Drug Delivery Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market size and projections, 2017 - 2028 (USD Million)
11.1.2. South America Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.1.3. South America Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
11.1.4. South America Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2. South America Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. Brazil Drug Delivery Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. Brazil Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.1.2. Brazil Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.1.3. Brazil Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2.2. Argentina Drug Delivery Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. Argentina Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.2.2. Argentina Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.2.3. Argentina Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
11.2.3. Rest of South America Drug Delivery Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Rest of South America Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
11.2.3.2. Rest of South America Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
11.2.3.3. Rest of South America Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 12. Middle East & Africa Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. Middle East & Africa Drug Delivery Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market size and projections, 2017 - 2028 (USD Million)
12.1.2. Middle East & Africa Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.1.3. Middle East & Africa Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
12.1.4. Middle East & Africa Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2. Middle East & Africa Drug Delivery Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. GCC Drug Delivery Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. GCC Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.1.2. GCC Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.1.3. GCC Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2.2. South Africa Drug Delivery Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. South Africa Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.2.2. South Africa Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.2.3. South Africa Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)
12.2.3. Rest of Middle East & Africa Drug Delivery Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of Middle East & Africa Drug Delivery Market Overview, By Route of Administration, 2017 - 2028 (USD Million)
12.2.3.2. Rest of Middle East & Africa Drug Delivery Market Overview, By Application, 2017 - 2028 (USD Million)
12.2.3.3. Rest of Middle East & Africa Drug Delivery Market Overview, By Distribution Channel, 2017 - 2028 (USD Million)

Chapter 13. Competitive Landscape
13.1. Competitive Environment, 2021
13.2. Strategic Framework
13.2.1. Partnership/Collaborations/Agreement
13.2.2. Expansion
13.2.3. Mergers & Acquisitions
13.2.4. New Product Development

Chapter 14. Key Vendor Analysis
14.1. Johnson & Johnson Services, Inc.
14.1.1. Business Overview
14.1.2. Product Benchmarking
14.1.3. Financial Data
14.1.4. Strategic Overview
14.1.5. Key Developments
14.1.6. SWOT Analysis
14.2. Novartis International AG
14.2.1. Business Overview
14.2.2. Product Benchmarking
14.2.3. Financial Data
14.2.4. Strategic Overview
14.2.5. Key Developments
14.2.6. SWOT Analysis
14.3. F. Hoffmann-La Roche AG
14.3.1. Business Overview
14.3.2. Product Benchmarking
14.3.3. Financial Data
14.3.4. Strategic Overview
14.3.5. Key Developments
14.3.6. SWOT Analysis
14.4. Pfizer Inc.
14.4.1. Business Overview
14.4.2. Product Benchmarking
14.4.3. Financial Data
14.4.4. Strategic Overview
14.4.5. Key Developments
14.4.6. SWOT Analysis
14.5. Bayer AG
14.5.1. Business Overview
14.5.2. Product Benchmarking
14.5.3. Financial Data
14.5.4. Strategic Overview
14.5.5. Key Developments
14.5.6. SWOT Analysis
14.6. Antares Pharma, Inc.
14.6.1. Business Overview
14.6.2. Product Benchmarking
14.6.3. Financial Data
14.6.4. Strategic Overview
14.6.5. Key Developments
14.6.6. SWOT Analysis
14.7. Becton
14.7.1. Business Overview
14.7.2. Product Benchmarking
14.7.3. Financial Data
14.7.4. Strategic Overview
14.7.5. Key Developments
14.7.6. SWOT Analysis
14.8. Dickinson and Company
14.8.1. Business Overview
14.8.2. Product Benchmarking
14.8.3. Financial Data
14.8.4. Strategic Overview
14.8.5. Key Developments
14.8.6. SWOT Analysis
14.9. GlaxoSmithKline plc
14.9.1. Business Overview
14.9.2. Product Benchmarking
14.9.3. Financial Data
14.9.4. Strategic Overview
14.9.5. Key Developments
14.9.6. SWOT Analysis
14.10. 3M
14.10.1. Business Overview
14.10.2. Product Benchmarking
14.10.3. Financial Data
14.10.4. Strategic Overview
14.10.5. Key Developments
14.10.6. SWOT Analysis
14.11. Merck & Co., Inc.
14.11.1. Business Overview
14.11.2. Product Benchmarking
14.11.3. Financial Data
14.11.4. Strategic Overview
14.11.5. Key Developments
14.11.6. SWOT Analysis
14.12. Sanofi
14.12.1. Business Overview
14.12.2. Product Benchmarking
14.12.3. Financial Data
14.12.4. Strategic Overview
14.12.5. Key Developments
14.12.6. SWOT Analysis

Chapter 15. Future Outlook of the Market